These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 5663423)

  • 21. Lead blood concentrations and renal function evaluation: study in an exposed Mexican population.
    Hernández-Serrato MI; Fortoul TI; Rojas-Martínez R; Mendoza-Alvarado LR; Canales-Treviño L; Bochichio-Riccardelli T; Avila-Costa MR; Olaiz-Fernández G
    Environ Res; 2006 Feb; 100(2):227-31. PubMed ID: 16442996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in some kidney functions in experimentally lead-poisoned goats.
    Gouda IM; Abdel Aziz SA; Lotfi MM; Ahmed AA; Soliman MM
    Arch Exp Veterinarmed; 1986 Mar; 40(2):242-9. PubMed ID: 3729659
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical evaluation of chronic, intermittent, and short term hemoperfusions in patients with chronic renal failure using semipermeable microcapsules (artificial cells) formed from membrane-coated activated charcoal.
    Chang TM; Gonda A; Dirks JH; Malave N
    Trans Am Soc Artif Intern Organs; 1971; 17():246-52. PubMed ID: 5158100
    [No Abstract]   [Full Text] [Related]  

  • 24. [Kidney involvement in industrial exposure to lead and cadmium].
    Balkarov IM; Dupliankin SA; Eliseeva NA; Kondakhchan MA; Barashkov GK; Lebedeva MV; Kriachnevskaia LN
    Ter Arkh; 1995; 67(5):34-6. PubMed ID: 7638774
    [No Abstract]   [Full Text] [Related]  

  • 25. Chronic folic acid-nephropathy.
    Schubert GE; Otten G
    Res Exp Med (Berl); 1974; 162(1):17-36. PubMed ID: 4810836
    [No Abstract]   [Full Text] [Related]  

  • 26. Azotaemia in severe head injury--central dysregulation or renal failure?
    Auer L; Holzer H; Tritthart H; Gell G
    Acta Neurochir (Wien); 1978; 41(4):355-61. PubMed ID: 685743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Early tubular involvements in lead poisoning in children].
    Gourrier E; Lamour C; Feldmann D; Bensman A
    Arch Fr Pediatr; 1991 Dec; 48(10):685-9. PubMed ID: 1793342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of homeostatic function of the kidneys in the development of hyperuricemia].
    Karvé MD; Shamarin VM; Vinogradova IV; Kiseleva NS; Ankhimiuk ON
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1989; (12):54-9. PubMed ID: 2624846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occult lead intoxication in patients with gout and kidney disease.
    Wright LF; Saylor RP; Cecere FA
    J Rheumatol; 1984 Aug; 11(4):517-20. PubMed ID: 6434739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occupational lead exposure, nephropathy, and renal cancer.
    Baker EL; Goyer RA; Fowler BA; Khettry U; Bernard DB; Adler S; White RD; Babayan R; Feldman RG
    Am J Ind Med; 1980; 1(2):139-48. PubMed ID: 7342761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Case of acute kidney failure from focal tubular necrosis and chronic lead nephropathy].
    Pucci F; Aguzzi P; Cacciamani G
    Radiol Med; 1982; 68(7-8):598-600. PubMed ID: 7134515
    [No Abstract]   [Full Text] [Related]  

  • 32. Mefenamic acid nephropathy.
    Robertson CE; Ford MJ; Van Someren V; Dlugolecka M; Prescott LF
    Lancet; 1980 Aug; 2(8188):232-3. PubMed ID: 6105396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ["Leaded" calcium oxalate calculi, or double lead colic].
    Ducret F; Pointet P; Girard C; Pin J
    Nouv Presse Med; 1982 Jul 10-17; 11(32):2420. PubMed ID: 7111014
    [No Abstract]   [Full Text] [Related]  

  • 34. Lead nephropathy and gout.
    Yu TF
    Am J Kidney Dis; 1983 Mar; 2(5):555-8. PubMed ID: 6829572
    [No Abstract]   [Full Text] [Related]  

  • 35. Renal dysfunction in Brazilian lead workers.
    Pinto de Almeida AR; Carvalho FM; Spinola AG; Rocha H
    Am J Nephrol; 1987; 7(6):455-8. PubMed ID: 3439554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of lead poisoning to renal impairment.
    Restek-Samarzija N; Momcilović B; Turk R; Samarzija M
    Arh Hig Rada Toksikol; 1997 Dec; 48(4):355-64. PubMed ID: 9721454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations among lead dose biomarkers, uric acid, and renal function in Korean lead workers.
    Weaver VM; Jaar BG; Schwartz BS; Todd AC; Ahn KD; Lee SS; Wen J; Parsons PJ; Lee BK
    Environ Health Perspect; 2005 Jan; 113(1):36-42. PubMed ID: 15626645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lead nephropathy--a preventable cause of renal failure.
    Pollock CA; Ibels LS
    Int J Artif Organs; 1988 Mar; 11(2):75-8. PubMed ID: 3131258
    [No Abstract]   [Full Text] [Related]  

  • 39. A 50-year follow-up of childhood plumbism. Hypertension, renal function, and hemoglobin levels among survivors.
    Hu H
    Am J Dis Child; 1991 Jun; 145(6):681-7. PubMed ID: 2035497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
    Sanaka T; Akizawa T; Koide K; Koshikawa S
    Ther Apher Dial; 2004 Jun; 8(3):232-40. PubMed ID: 15154877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.